.65, but alas the DX SP has popped 33% at time of writing on the announcement of the FDA approval. However, based on other similar situtations, I am pretty confident the SP will fall back over the coming weeks and months, in the absence of any major deal announcements. OK, so here are some notes on why I think today's announcement is transformational. Remember, it comes on the back of signification acceleration of SaaS sales, i.e., +95% FY25 over FY25. FDA appro…","url":"https://www.strawman.com/forums/topic/11768","discussionUrl":"https://www.strawman.com/forums/topic/11768","author":{"@type":"Person","name":"Michael Hollewand","alternateName":"mikebrisy","url":"https://www.strawman.com/members/mikebrisy"},"isPartOf":{"@type":"WebSite","name":"Strawman","url":"https://www.strawman.com"},"description":"Well, I tried to get more at .65, but alas the DX SP has popped 33% at time of writing on the announcement of the FDA approval. However, based on other sim…","datePublished":"2025-09-01T12:57:38+10:00"}